Cancer Metabolomics 2018

• Egile nagusia: Pinto, Joana (auth)
• Beste egile batzuk: Carvalho, Márcia (auth), De Pinho, Paula Guedes (auth)
• Formatua: Baliabide elektronikoa Liburu kapitulua
• Hizkuntza: ingelesa
• Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2019
• Gaiak: Biology, life sciences; cell transporters; pharmacodynamics; cell growth; in vitro study; metabolomic signatures; endometabolome; lung cancer; metabolomics; chemometric methods; bladder cancer; mTOR; metabolite profiling; metabolic pathways; hepatocellular carcinoma; glutamate; senescence MCF7; breath analysis; bio actives; biomarker; gas chromatography-mass spectrometry (GC-MS); GC-MS; lung; omics; nutraceuticals; glutaminase; metabolism; acylcarnitines; Erwinaze; Kidrolase; glutathione; targeted metabolomics; apoptosis; SLC1A5; essential amino acids; cancer progression; ASCT2; HR MAS; alanine; analytical platforms; volatile organic compound; glutaminolysis; isotope tracing analysis; asparaginase; vitamin E; breast cancer; prognosis; early diagnosis; tocotrienols; NMR; prostate cancer; in vitro; cancer; MDA-MB-231
• Sarrera elektronikoa: DOAB: download the publication; DOAB: description of the publication

The metabolomics approach, defined as the study of all endogenously-produced low-molecular-weight compounds, appeared as a promising strategy to define new cancer biomarkers. Information obtained from metabolomic data can help to highlight disrupted cellular pathways and, consequently, contribute to...